{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:28:35Z","timestamp":1787768915581,"version":"build-2784847793"},"reference-count":24,"publisher":"Gobierno de Navarra","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["An Sist Sanit Navar"],"DOI":"10.23938\/assn.1081","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T04:06:47Z","timestamp":1722917207000},"source":"Crossref","is-referenced-by-count":5,"title":["Biomarkers of oxidative stress and inflammation in contrast-associated acute kidney injury"],"prefix":"10.23938","volume":"47","author":[{"given":"Elisabeth","family":"Stoll","sequence":"first","affiliation":[{"name":"Cl\u00ednica Universidad de Navarra. Departamento de Anestesia y Cuidados Intensivos. Pamplona. Espa\u00f1a. estoll@unav.es"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Monedero","sequence":"additional","affiliation":[{"name":"Cl\u00ednica Universidad de Navarra. Departamento de Anestesia y Cuidados Intensivos. Pamplona. Espa\u00f1a. pmonedero@unav.es"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paloma L","family":"Martin-Moreno","sequence":"additional","affiliation":[{"name":"Cl\u00ednica Universidad de Navarra. Departamento de Nefrolog\u00eda. Pamplona. Espa\u00f1a. pmonedero@unav.es"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Garcia-Fernandez","sequence":"additional","affiliation":[{"name":"Cl\u00ednica Universidad de Navarra. Departamento de Nefrolog\u00eda. Pamplona. Espa\u00f1a. nrgarcia@unav.es"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10024","published-online":{"date-parts":[[2024,8,5]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. CHAUDHARI H, MAHENDRAKAR S, BASKIN SE, REDDI AS. Contrast-induced acute kidney injury: evidence in support of its existence and a review of its pathogenesis and management. Int J Nephrol Renovasc Dis 2022;15:253-266. https:\/\/doi.org\/10.2147\/IJNRD.S371700","DOI":"10.2147\/IJNRD.S371700"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. STANSKI NL, RODRIGUES CE, STRADER M, MURRAY PT, ENDRE ZH, BAGSHAW SM. Precision management of acute kidney injury in the intensive care unit: current state of the art. Intensive Care Med 2023; 49(9): 1049-1061. https:\/\/doi.org\/10.1007\/s00134-023-07171-z","DOI":"10.1007\/s00134-023-07171-z"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. CHENG W, ZHAO F, TANG CY, LI XW, LUO M, DUAN SB. Comparison of iohexol and iodixanol induced nephrotoxicity, mitochondrial damage and mitophagy in a new contrast-induced acute kidney injury rat model. Arch Toxicol 2018; 92: 2245-2257. https:\/\/doi.org\/10.1007\/s00204-018-2225-9","DOI":"10.1007\/s00204-018-2225-9"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. VLACHOPANOS G, SCHIZAS D, HASEMAKI N, GEORGALIS A. Pathophysiology of contrast-induced acute kidney injury (CIAKI). Curr Pharm Des 2019; 25(44): 4642-4647. https:\/\/doi.org\/10.2174\/1381612825666191210152944","DOI":"10.2174\/1381612825666191210152944"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. CHO E, KO GJ. the pathophysiology and the management of radiocontrast-induced nephropathy. Diagnostics (Basel) 2022; 12(1): 180. https:\/\/doi.org\/10.3390\/diagnostics12010180","DOI":"10.3390\/diagnostics12010180"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. D'AMORE C, NUZZO S, BRIGUORI C. Biomarkers of contrast-induced nephropathy: Which ones are clinically important? Interv Cardiol Clin 2020; 9: 335-344. https:\/\/doi.org\/10.1016\/j.iccl.2020.02.004","DOI":"10.1016\/j.iccl.2020.02.004"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. SCHREZENMEIER EV, BARASCH J, BUDDE K, WESTHOFF T, SCHMIDT-OTT KM. Biomarkers in acute kidney injury - pathophysiological basis and clinical performance. Acta Physiol (Oxf) 2017; 219: 554-572. https:\/\/doi.org\/10.1111\/apha.12764","DOI":"10.1111\/apha.12764"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. BIRKELO BC, PANNU N, SIEW ED. Overview of diagnostic criteria and epidemiology of acute kidney injury and acute kidney disease in the critically ill patient. Clin J Am Soc Nephrol 2022; 17:717-735. https:\/\/doi.org\/10.2215\/CJN.14181021","DOI":"10.2215\/CJN.14181021"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. AOUN J, NICOLAS D, BROWN JR, JABER BL. Maximum allowable contrast dose and prevention of acute kidney injury following cardiovascular procedures. Curr Opin Nephrol Hypertens 2018; 27: 121-129. https:\/\/doi.org\/10.1097\/MNH.0000000000000389","DOI":"10.1097\/MNH.0000000000000389"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. FERNANDEZ-RUIZ V, KAWA M, BERASAIN C, I\u00d1IGUEZ M, SCHMITZ V, MARTINEZ-ANS\u00d3 E et al. Treatment of murine fulminant hepatitis with genetically engineered endothelial progenitor cells. J Hepatol 2011; 55: 828-837. https:\/\/doi.org\/10.1016\/j.jhep.2011.01.036","DOI":"10.1016\/j.jhep.2011.01.036"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11 Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Inter Suppl 2012; 2 (Suppl 1): 1-138. https:\/\/doi.org\/10.1038\/kisup.2012.2","DOI":"10.1038\/kisup.2012.2"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. MARTIN-MORENO PL, VARO N, MART\u00cdNEZ-ANS\u00d3 E, MARTIN-CALVO N, SAY\u00d3N-OREA C, BILBAO JI, GARCIA-FERNANDEZ N. Comparison of intravenous and oral hydration in the prevention of contrast-induced acute kidney injury in low-risk patients: A randomized trial. Nephron 2015; 131(1): 51-58. https:\/\/doi.org\/10.1159\/000438907","DOI":"10.1159\/000438907"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. MCDONALD JS, MCDONALD RJ. Risk of acute kidney injury following IV iodinated contrast media exposure: 2023 update, from the AJR special series on contrast media. AJR Am J Roentgenol 2024. https:\/\/doi.org\/10.2214\/AJR.23.30037","DOI":"10.2214\/AJR.23.30037"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. S\u016eVA M, KALA P, POLOCZEK M, KA\u0147OVSK\u00dd J, \u0160T\u00cdPAL R, RADVAN M et al. Contrast-induced acute kidney injury and its contemporary prevention. Front Cardiovasc Med 2022; 9: 1073072. https:\/\/doi.org\/10.3389\/fcvm.2022.1073072","DOI":"10.3389\/fcvm.2022.1073072"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. WEISBORD SD, GALLAGHER M, JNEID H, GARCIA S, CASS A, THWIN SS et al. PRESERVE trial group. outcomes after angiography with sodium bicarbonate and acetylcysteine. N Engl J Med 2018; 378(7): 603-614. https:\/\/doi.org\/10.1056\/NEJMoa1710933","DOI":"10.1056\/NEJMoa1710933"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. LIANGOS O, KOLYADA A, TIGHIOUART H, PERIANAYAGAM MC, WALD R, JABER BL. Interleukin-8 and acute kidney injury following cardiopulmonary bypass: a prospective cohort study. Nephron Clin Pract 2009 ;113(3): c148-c154. https:\/\/doi.org\/10.1159\/000232595","DOI":"10.1159\/000232595"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. MARAKALA V. Neutrophil gelatinase-associated lipocalin (NGAL) in kidney injury - A systematic review. Clin Chim Acta 2022; 536: 135-141. https:\/\/doi.org\/10.1016\/j.cca.2022.08.029","DOI":"10.1016\/j.cca.2022.08.029"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. FILIOPOULOS V, BIBLAKI D, VLASSOPOULOS D. Neutrophil gelatinase-associated lipocalin (NGAL): a promising biomarker of contrast-induced nephropathy after computed tomography. Ren Fail 2014; 36(6): 979-986. https:\/\/doi.org\/10.3109\/0886022X.2014.900429","DOI":"10.3109\/0886022X.2014.900429"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. MAGNO AL, HERAT LY, CARNAGARIN R, SCHLAICH MP, MATTHEWS VB. CURRENT knowledge of IL-6 cytokine family members in acute and chronic kidney disease. Biomedicines 2019; 7(1): 19. https:\/\/doi.org\/10.3390\/biomedicines7010019","DOI":"10.3390\/biomedicines7010019"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. QUIROS Y, S\u00c1NCHEZ-GONZ\u00c1LEZ PD, L\u00d3PEZ-HERN\u00c1NDEZ FJ, MORALES AI, L\u00d3PEZ-NOVOA JM. Cardiotrophin-1 administration prevents the renal toxicity of iodinated contrast media in rats. Toxicol Sci 2013; 132(2): 493-501. https:\/\/doi.org\/10.1093\/toxsci\/kft007","DOI":"10.1093\/toxsci\/kft007"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. NALESSO F, CATTARIN L, GOBBI L, FRAGASSO A, GARZOTTO F, CAL\u00d2 LA. Evaluating nephrocheck\u00ae as a predictive tool for acute kidney injury. Int J Nephrol Renovasc Dis 2020; 13: 85-96. https:\/\/doi.org\/10.2147\/IJNRD.S198222","DOI":"10.2147\/IJNRD.S198222"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22. ROUVE E, LAKHAL K, SALMON GANDONNI\u00c8RE C, JOUAN Y, BODET-CONTENTIN L, EHRMANN S. Lack of impact of iodinated contrast media on kidney cell-cycle arrest biomarkers in critically ill patients. BMC Nephrol 2018; 19(1): 308. https:\/\/doi.org\/10.1186\/s12882-018-1091-2","DOI":"10.1186\/s12882-018-1091-2"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23. PICKKERS P, DARMON M, HOSTE E, JOANNIDIS M, LEGRAND M, OSTERMANN M et al. Acute kidney injury in the critically ill: An updated review on pathophysiology and management. Intensive Care Med 2021; 47(8): 835-850. https:\/\/doi.org\/10.1007\/s00134-021-06454-7","DOI":"10.1007\/s00134-021-06454-7"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24. MCCULLOUGH PA. Renal safety of iodixanol. Expert Rev Cardiovasc Ther 2006; 4: 655-661. https:\/\/doi.org\/10.1586\/14779072.4.5.655","DOI":"10.1586\/14779072.4.5.655"}],"container-title":["Anales del Sistema Sanitario de Navarra"],"original-title":[],"link":[{"URL":"https:\/\/recyt.fecyt.es\/index.php\/ASSN\/article\/view\/106115\/79459","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T07:02:57Z","timestamp":1779346977000},"score":1,"resource":{"primary":{"URL":"https:\/\/recyt.fecyt.es\/index.php\/ASSN\/article\/view\/106115\/79459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,5]]},"references-count":24,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,8,5]]}},"URL":"https:\/\/doi.org\/10.23938\/assn.1081","relation":{},"ISSN":["2340-3527"],"issn-type":[{"value":"2340-3527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,5]]},"article-number":"e1081"}}